Red cell antigen exposures in patients with sickle cell disease receiving transfusion from Black and Hispanic donors

Read full text
Authors: Julia Mewha, Sunitha Vege, David F. Friedman, Shaimaa Makrm, Gorka Ochoa, Connie M. Westhoff, Stella T. Chou
Cited by: 1
References: 20

Abstract

F0B7 Rh and K-matched red cell units from racially similar donors minimizes foreign antigen exposure to 1.6 per transfusion for patients with SCD F0B7 Among 35 antigens, 22% of units from self-declared Black donors had no foreign antigen exposure to the recipient with SCD. Patients with sickle cell disease (SCD) have an elevated risk for alloimmunization due to frequent transfusions and antigenic disparities with donors. Extended antigen matching beyond Rh (CcEe) and Kell (K) can reduce alloimmunization but is not broadly applied due to logistic and economic challenges. Red cell antigen exposures may be minimized when donor and patient populations are from similar racial and ethnic backgrounds. This study assessed alloantigen exposure across 35 antigens in patients with SCD receiving transfusions from donors self-identifying as Black or Hispanic. Seven hundred units transfused to 28 chronically transfused patients were genotyped using a single nucleotide polymorphism-based assay. Combining Rh and K-matching with donor unit selection from racially similar populations, patients were exposed to an average of 1.6 antigens per transfusion, compared to the previously reported 3.5 exposures per transfusion across the same 35 antigens using a general donor inventory. Among 514 units transfused to Black recipients from Black donors, 22% had no foreign antigen exposure of 35 antigens. The most frequent alloantigen exposures were Jk b , S, and Do a . One clinically significant anti-Jk b formed during the study. These findings suggest combining donor unit selection with blood group genotyping may improve compatibility and transfusion safety for high-risk populations.

Fields of Study & Subjects

Blood groups and transfusion Blood transfusion and management Hemoglobinopathies and Related Disorders

Publication details

Journal / source
Blood Red Cells & Iron
Publisher
Elsevier BV
Volume
2
Issue
2
Pages
100059–100059
Publication date
5 February 2026
Language
EN